Q1 2024 · 13F-HR
DAFNA Capital Management LLCholdings as filed
Filed 2024-05-15 · accession 0001389932-24-000012
$439.3M
Reported value
72
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $40.9M | 9.31% | 431,215 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $35.7M | 8.13% | 13,680,554 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $27.9M | 6.35% | 398,100 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $19.6M | 4.46% | 446,341 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $17.1M | 3.89% | 378,995 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $16.5M | 3.76% | 511,894 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $15.9M | 3.62% | 194,117 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $15.7M | 3.57% | 659,574 | Common | SOLE |
| 464287556 | IBB | ISHARES NASDAQ BIOTECH INDX | $14.1M | 3.20% | 102,500 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $14.0M | 3.18% | 92,472 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $11.8M | 2.68% | 273,739 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $11.0M | 2.51% | 666,463 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $10.1M | 2.31% | 106,763 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $9.9M | 2.25% | 71,615 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $9.6M | 2.18% | 806,973 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $9.1M | 2.08% | 258,208 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $9.1M | 2.07% | 65,552 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $8.8M | 2.00% | 412,663 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $8.2M | 1.88% | 271,029 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HOLDING INC | $8.2M | 1.86% | 231,748 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $7.6M | 1.72% | 935,894 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $6.5M | 1.48% | 118,730 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $6.4M | 1.47% | 1,204,051 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $5.6M | 1.27% | 306,197 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $5.5M | 1.25% | 912,928 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $5.5M | 1.24% | 1,307,407 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $5.0M | 1.13% | 656,373 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $4.6M | 1.05% | 4,000,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $4.5M | 1.02% | 67,754 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $4.4M | 1.00% | 231,717 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $4.2M | 0.95% | 130,175 | Common | SOLE |
| 46489V104 | ISREUR | PERSPECTIVE THERAPEUTICS INC | $3.7M | 0.84% | 3,103,644 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $3.6M | 0.82% | 709,500 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $3.1M | 0.72% | 223,265 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $3.1M | 0.70% | 1,070,548 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $3.0M | 0.69% | 122,200 | Common | SOLE |
| 004397105 | ARAY | ACCURAY INC | $3.0M | 0.69% | 1,222,358 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $2.7M | 0.62% | 15,900 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $2.7M | 0.62% | 54,995 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $2.7M | 0.61% | 188,753 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $2.4M | 0.56% | 239,194 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $2.1M | 0.48% | 500,000 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $2.1M | 0.47% | 905,582 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $2.0M | 0.46% | 243,210 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $2.0M | 0.46% | 1,366,308 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.0M | 0.45% | 145,000 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $1.9M | 0.43% | 334,079 | Common | SOLE |
| 45780L104 | INGN | INOGEN INC | $1.7M | 0.38% | 208,790 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.7M | 0.38% | 1,409,262 | Common | SOLE |
| 10501L106 | BWAY | BRAINSWAY LTD | $1.6M | 0.36% | 297,655 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $1.6M | 0.36% | 17,000 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $1.5M | 0.35% | 145,000 | Common | SOLE |
| 64131A105 | STIM | NEURONETICS INC | $1.5M | 0.34% | 313,717 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $1.4M | 0.32% | 600,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.4M | 0.31% | 216,667 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $1.4M | 0.31% | 202,587 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.3M | 0.31% | 98,560 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.2M | 0.26% | 90,000 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $1.1M | 0.25% | 430,202 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $950,431 | 0.22% | 29,416 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $939,160 | 0.21% | 131,351 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $917,694 | 0.21% | 137,174 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $853,052 | 0.19% | 185,446 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $726,798 | 0.17% | 135,850 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $538,881 | 0.12% | 341,064 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $440,550 | 0.10% | 3,000 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $404,320 | 0.09% | 28,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $290,944 | 0.07% | 192,678 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $244,889 | 0.06% | 71,815 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $231,426 | 0.05% | 116,882 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $215,000 | 0.05% | 125,000 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $153,500 | 0.03% | 10,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.